AGIOS PHARMACEUTICALS, INC. Stockholders Equity

Quick Answer

AGIOS PHARMACEUTICALS, INC. reported Stockholders Equity of $1.19 billion for the year ending 2025.

  • AGIOS PHARMACEUTICALS, INC. showed a decrease of -22.6% in Stockholders Equity from 2024 to 2025.
  • This data is from AGIOS PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2014: $121.34 million | Q2 2014: $200.55 million | Q3 2014: $207.75 million | Q1 2015: $426.82 million | Q2 2015: $404.17 million | Q3 2015: $375.66 million | Q1 2016: $332.37 million | Q2 2016: $289.08 million | Q3 2016: $401.45 million | Q1 2017: $307.38 million | Q2 2017: $508.99 million | Q3 2017: $449.81 million | Q1 2018: $865.59 million | Q2 2018: $823.14 million | Q3 2018: $760.21 million | Q1 2019: $620.26 million | Q2 2019: $532.68 million | Q3 2019: $448.29 million | Q1 2020: $625.30 million | Q2 2020: $558.47 million | Q3 2020: $480.45 million | Q1 2021: $2.30 billion | Q2 2021: $1.72 billion | Q3 2021: $1.39 billion | Q1 2022: $1.21 billion | Q2 2022: $1.12 billion | Q3 2022: $1.05 billion | Q1 2023: $1.04 billion | Q2 2023: $964.24 million | Q3 2023: $886.84 million | Q1 2024: $743.92 million | Q2 2024: $660.51 million | Q3 2024: $1.63 billion | Q1 2025: $1.47 billion | Q2 2025: $1.37 billion | Q3 2025: $1.28 billion.
  • Over the full 15 years of available data (2011 to 2025), AGIOS PHARMACEUTICALS, INC.'s Stockholders Equity has grown by 2,360.5%.
  • Historical annual values: Fiscal year 2025: $1.19 billion | Fiscal year 2024: $1.54 billion | Fiscal year 2023: $811.02 million | Fiscal year 2022: $1.10 billion | Fiscal year 2021: $1.29 billion | Fiscal year 2020: $399.50 million | Fiscal year 2019: $640.53 million | Fiscal year 2018: $687.54 million | Fiscal year 2017: $375.50 million | Fiscal year 2016: $358.59 million | Fiscal year 2015: $345.12 million | Fiscal year 2014: $424.37 million | Fiscal year 2013: $131.48 million | Fiscal year 2012: -$72.02 million | Fiscal year 2011: -$52.78 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: